Tetra Bio Pharma Inc (TBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 08-2022 | 05-2022 | 02-2022 | 11-2021 | 08-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 22 | 22 | 22 | 36 | 27 |
| Accounts receivable | 426 | 551 | -2,304 | 33 | 248 |
| Other Working Capital | 2,392 | 1,103 | -1,117 | 1,787 | -2,276 |
| Other Operating Activity | -3,713 | -3,594 | 1,008 | -4,858 | -5,550 |
| Operating Cash Flow | $-874 | $-1,917 | $-2,391 | $-3,002 | $-7,551 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | -11 | -98 |
| Net Acquisitions | 0 | 0 | 0 | -653 | 0 |
| Purchase Sale Intangibles | 0 | 0 | 0 | -20 | -42 |
| Investing Cash Flow | $0 | $0 | $0 | $-684 | $-140 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -378 | -498 | -575 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 2,129 | -1,500 | 0 |
| Other Financing Activity | 0 | 480 | -378 | 1,500 | 27 |
| Financing Cash Flow | $-378 | $-18 | $1,176 | $0 | $27 |
| Beginning Cash Position | 1,735 | 3,671 | 4,886 | 8,572 | 16,236 |
| End Cash Position | 483 | 1,735 | 3,671 | 4,886 | 8,572 |
| Net Cash Flow | $-1,252 | $-1,936 | $-1,215 | $-3,686 | $-7,664 |
| Free Cash Flow | |||||
| Operating Cash Flow | -874 | -1,917 | -2,391 | -3,002 | -7,551 |
| Capital Expenditure | N/A | N/A | N/A | -31 | -140 |
| Free Cash Flow | -874 | -1,917 | -2,391 | -3,033 | -7,691 |